Table 7.
Trust toward biobanking institutions
| Definitely not | Rather not | I do not know | Rather yes | Definitely yes | Median (IQR) | p | Rank-biserial correlation | 95% CI for Rank-biserial correlation | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||||
| Would you donate the sample of your biological material to research to | ||||||||||
| Medical university | ||||||||||
| Religious students (RS) | 9 | 21 | 17 | 197 | 212 | 4 (4–5) | < 0.001 | 0.165 | 0.103 | 0.226 |
| Nonreligious students (NRS) | 4 | 28 | 20 | 348 | 644 | 5 (4–5) | ||||
| Public clinical hospital | ||||||||||
| RS | 16 | 68 | 28 | 216 | 128 | 4 (4–5) | < 0.001 | 0.099 | 0.036 | 0.161 |
| NRS | 19 | 126 | 53 | 475 | 371 | 4 (4–5) | ||||
| Private clinical hospital | ||||||||||
| RS | 23 | 83 | 29 | 220 | 101 | 4 (3–4) | < 0.01 | 0.078 | 0.015 | 0.141 |
| NRS | 35 | 160 | 62 | 503 | 284 | 4 (4–5) | ||||
| Polish biobank | ||||||||||
| RS | 17 | 39 | 35 | 265 | 100 | 4 (4–4) | < 0.05 | 0.073 | 0.009 | 0.136 |
| NRS | 25 | 93 | 69 | 555 | 302 | 4 (4–5) | ||||
| Foreign biobank | ||||||||||
| RS | 47 | 118 | 40 | 185 | 66 | 4 (2–4) | < 0.001 | 0.198 | 0.137 | 0.259 |
| NRS | 33 | 176 | 112 | 484 | 239 | 4 (3–4) | ||||
| Private biobank | ||||||||||
| RS | 50 | 116 | 53 | 183 | 54 | 4 (2–4) | < 0.001 | 0.105 | 0.041 | 0.167 |
| NRS | 67 | 234 | 133 | 433 | 177 | 4 (2–4) | ||||
| Public biobank | ||||||||||
| RS | 31 | 86 | 54 | 223 | 62 | 4 (2–4) | < 0.001 | 0.136 | 0.073 | 0.198 |
| NRS | 29 | 134 | 125 | 556 | 200 | 4 (3–4) | ||||
| Polish pharmaceutical company | ||||||||||
| RS | 61 | 122 | 47 | 177 | 49 | 3 (2–4) | < 0.01 | 0.094 | 0.030 | 0.156 |
| NRS | 95 | 226 | 140 | 448 | 135 | 4 (2–4) | ||||
| Foreign pharmaceutical company | ||||||||||
| RS | 87 | 143 | 49 | 133 | 44 | 2 (2–4) | < 0.001 | 0.157 | 0.095 | 0.219 |
| NRS | 113 | 264 | 146 | 390 | 131 | 3 (2–4) | ||||
| Would you donate to a biobank if your biological samples would be accessible to: | ||||||||||
| Only researchers from the institution one donated to | ||||||||||
| RS | 4 | 6 | 10 | 162 | 274 | 5 (4–5) | < 0.001 | 0.137 | 0.074 | 0.199 |
| NRS | 4 | 5 | 10 | 259 | 766 | 5 (4–5) | ||||
| Researchers from domestic scientific institutions | ||||||||||
| RS | 11 | 34 | 20 | 242 | 149 | 4 (4–5) | < 0.001 | 0.128 | 0.065 | 0.190 |
| NRS | 7 | 73 | 25 | 477 | 462 | 4 (4–5) | ||||
| Researchers from domestic commercial companies, including pharmaceutical industry | ||||||||||
| RS | 72 | 161 | 37 | 139 | 47 | 2 (2–4) | < 0.01 | 0.082 | 0.018 | 0.145 |
| NRS | 138 | 311 | 102 | 363 | 130 | 3 (2–4) | ||||
| Researchers from foreign scientific institutions | ||||||||||
| RS | 38 | 57 | 28 | 233 | 100 | 4 (3–4) | < 0.001 | 0.236 | 0.175 | 0.295 |
| NRS | 28 | 70 | 45 | 491 | 410 | 4 (4–5) | ||||
| Researchers from foreign commercial companies, including pharmaceutical industry | ||||||||||
| RS | 100 | 166 | 38 | 117 | 35 | 2 (2–4) | < 0.001 | 0.146 | 0.083 | 0.207 |
| NRS | 159 | 322 | 103 | 332 | 128 | 3 (2–4) | ||||
| Polish and foreign insurance companies | ||||||||||
| RS | 207 | 176 | 31 | 30 | 12 | 2 (1–2) | ns | 0.028 | − 0.036 | 0.091 |
| NRS | 467 | 370 | 83 | 81 | 43 | 2 (1–2) | ||||
| Government institutions | ||||||||||
| RS | 208 | 149 | 42 | 48 | 9 | 2 (1–2) | < 0.01 | − 0.079 | − 0.142 | − 0.016 |
| NRS | 556 | 301 | 78 | 82 | 27 | 1 (1–2) | ||||
| Police | ||||||||||
| RS | 178 | 133 | 53 | 78 | 14 | 2 (1–3) | < 0.01 | − 0.086 | − 0.149 | − 0.023 |
| NRS | 481 | 301 | 86 | 151 | 25 | 2 (1–3) | ||||
| When should a research biobank ask the donor for permission to use one’s samples? | ||||||||||
| Before every new research | ||||||||||
| RS | 13 | 59 | 8 | 113 | 263 | 5 (4–5) | < 0.001 | − 0.169 | − 0.230 | − 0.106 |
| NRS | 51 | 218 | 53 | 266 | 456 | 4 (2–5) | ||||
| If a new research differs from the original | ||||||||||
| RS | 10 | 32 | 5 | 118 | 291 | 5 (4–5) | < 0.001 | − 0.108 | − 0.171 | − 0.045 |
| NRS | 31 | 107 | 34 | 308 | 564 | 5 (4–5) | ||||
| If it is going to be used by researchers outside the institution one donated to | ||||||||||
| RS | 4 | 16 | 7 | 77 | 352 | 5 (5–5) | < 0.01 | − 0.072 | − 0.135 | − 0.009 |
| NRS | 18 | 67 | 16 | 207 | 736 | 5 (4–5) | ||||
| If it is going to be used by foreign institutions | ||||||||||
| RS | 3 | 19 | 7 | 87 | 340 | 5 (4–5) | < 0.001 | − 0.124 | − 0.186 | − 0.061 |
| NRS | 21 | 103 | 22 | 235 | 663 | 5 (4–5) | ||||
| Does not have to ask if the doner consent while donating | ||||||||||
| RS | 205 | 99 | 25 | 70 | 57 | 2 (1–4) | < 0.01 | 0.098 | 0.035 | 0.161 |
| NRS | 362 | 253 | 110 | 178 | 141 | 2 (1–4) | ||||
The statistically significant results are given in boldface
ns statistically not significant